Virtu Financial (VIRT)
(Delayed Data from NSDQ)
$31.39 USD
-0.17 (-0.54%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $31.39 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
A Value F Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$31.39 USD
-0.17 (-0.54%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $31.39 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
A Value F Growth C Momentum C VGM
Zacks News
Is a Surprise Coming for Virtu Financial (VIRT) This Earnings Season?
by Zacks Equity Research
Virtu Financial (VIRT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in Store for Regional Management (RM) in Q1 Earnings?
by Zacks Equity Research
Regional Management (RM) first-quarter 2020 results are expected to reflect a rise in interest income, partially offset by higher expenses.
What's in the Cards for Main Street (MAIN) in Q1 Earnings?
by Zacks Equity Research
Main Street's (MAIN) first-quarter 2020 results are expected to reflect a fall in interest income due to lower rates.
How Badly Will Coronavirus Hit Global Payments (GPN) Q1 Earnings?
by Zacks Equity Research
Global Payments' (GPN) Q1 results are likely to reflect earnings erosion from the coronavirus-led business loss.
Everest Re (RE) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Everest Re (RE) Q1 performance is likely to have benefited from higher net investment income, increased insurance premiums and strong capital position.
What's in Store for Virtu Financial's (VIRT) Q1 Earnings?
by Zacks Equity Research
Virtu Financial's (VIRT) Q1 results are likely to reflect gains from the market volatility induced by COVID-19.
What's in the Cards for Western Union's (WU) Q1 Earnings?
by Zacks Equity Research
Western Union's (WU) first-quarter results are likely to reflect softer revenues at its C2C segment, partially offset by continued share buybacks.
What's in Store for Assurant (AIZ) This Earnings Season?
by Zacks Equity Research
Assurant's (AIZ) Q1 results are likely to reflect strong growth in Global Automotive and the expansion of mobile programs and expansion of Specialty Property and Multifamily Housing businesses.
Unum (UNM) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Unum's (UNM) first-quarter 2020 results are likely to reflect strong segmental performance courtesy of improved premiums.
Virtu Financial (VIRT) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Virtu Financial (VIRT) closed at $23.37 in the latest trading session, marking a -1.14% move from the prior day.
Virtu Financial (VIRT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Virtu Financial (VIRT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CME Group's (CME) Q1 Earnings Top Estimates, Revenues Up Y/Y
by Zacks Equity Research
CME Group's (CME) first-quarter 2020 results indicate strong revenues arising from increased volumes.
The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Sprouts Farmers Market, The Hain Celestial, Virtu Financial and Pixelworks
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Sprouts Farmers Market, The Hain Celestial, Virtu Financial and Pixelworks
Will Higher Transactions Processed Aid Visa (V) Q2 Earnings?
by Zacks Equity Research
A spurt in the number of transactions processed across all major geographic regions is likely to have aided Visa's (V) Q2 earnings.
Cboe Global (CBOE) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Cboe Global's (CBOE) first-quarter 2020 performance is likely to have benefited from acquisition and lower expenses, offset by lower transaction fees.
5 Top-Ranked Nasdaq Stocks to Buy Ahead of Earnings Results
by Nalak Das
Despite the coronavirus-induced economic disaster and stock market turmoil, a handful of Nasdaq stocks are set to beat earnings estimates.
Will Coronavirus-Led Business Loss Mar Visa (V) Q2 Earnings?
by Zacks Equity Research
Erosion of business volumes due to coronavirus-led disruption is likely to have dented Visa's (V) Q2 earnings.
What Awaits Intercontinental Exchange (ICE) in Q1 Earnings?
by Zacks Equity Research
Intercontinental Exchange's (ICE) first-quarter 2020 results are likely to reflect strong data services revenues and share buybacks.
Top Ranked Income Stocks to Buy for April 27th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, April 27th.
Will Coronavirus Fallout Mar Mastercard's (MA) Q1 Earnings?
by Sapna Bagaria
A reduction in overall spending across the globe is likely to have dimmed Mastercard's (MA) Q1 earnings prospects. Also, high expenses might have drained its margins.
American Express (AXP) Q1 Earnings Beat Despite Coronavirus
by Zacks Equity Research
American Express' (AXP) Q1 earnings beat as the decline in revenues was more than compensated by a greater decrease in expenses.
What's in Store for Affiliated Managers (AMG) in Q1 Earnings?
by Zacks Equity Research
Affiliated Managers' (AMG) first-quarter 2020 performance is expected to have been hurt by a decline in assets.
Is Virtu Financial (VIRT) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Is (VIRT) Outperforming Other Finance Stocks This Year?
The Zacks Analyst Blog Highlights: Clorox, Manning & Napier, Virtu Financial, PLDT and The Scotts Miracle-Gro
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Clorox, Manning & Napier, Virtu Financial, PLDT and The Scotts Miracle-Gro
Discover Financial's (DFS) Q1 Earnings Miss, Tumble Y/Y
by Zacks Equity Research
Discover Financial's (DFS) first-quarter earnings take a hit from the coronavirus effect.